Johnson & Johnson Considers Spin-Off of Orthopedics Business Unit

Key Facts

1Johnson & Johnson CFO Joseph Wolk stated the company is leaning toward spinning out its hips-and-knees business unit.

Johnson & Johnson JNJ CFO Joseph Wolk stated the company is leaning toward spinning out its hips-and-knees business unit. The Wall Street Journal reported that the healthcare firm is considering the move for its orthopedic segment.

The company is exploring the spin-off to potentially streamline operations or unlock shareholder value within this specific business unit. JNJ shares closed at $263.73 on October 12, 2026, having traded between a high of $264.39 and a low of $260.37 during that session.